249 related articles for article (PubMed ID: 16875831)
1. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?
Shields KG; Goadsby PJ
Neurobiol Dis; 2006 Sep; 23(3):491-501. PubMed ID: 16875831
[TBL] [Abstract][Full Text] [Related]
2. GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus.
Andreou AP; Shields KG; Goadsby PJ
Neurobiol Dis; 2010 Feb; 37(2):314-23. PubMed ID: 19837163
[TBL] [Abstract][Full Text] [Related]
3. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?
Shields KG; Goadsby PJ
Brain; 2005 Jan; 128(Pt 1):86-97. PubMed ID: 15574468
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors.
Goadsby PJ; Knight Y
Br J Pharmacol; 1997 Nov; 122(5):918-22. PubMed ID: 9384509
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
[TBL] [Abstract][Full Text] [Related]
6. Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy.
Boers PM; Donaldson C; Zagami AS; Lambert GA
Cephalalgia; 2004 Feb; 24(2):99-109. PubMed ID: 14728705
[TBL] [Abstract][Full Text] [Related]
7. The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat.
Hoskin KL; Lambert GA; Donaldson C; Zagami AS
Brain Res; 2004 Feb; 998(1):91-9. PubMed ID: 14725972
[TBL] [Abstract][Full Text] [Related]
8. The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons.
Donaldson C; Boers PM; Hoskin KL; Zagami AS; Lambert GA
Neuropharmacology; 2002 Mar; 42(3):374-85. PubMed ID: 11897116
[TBL] [Abstract][Full Text] [Related]
9. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat.
Hoskin KL; Goadsby PJ
Exp Neurol; 1998 Mar; 150(1):45-51. PubMed ID: 9514827
[TBL] [Abstract][Full Text] [Related]
10. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input.
Goadsby PJ; Classey JD
Neuroscience; 2003; 122(2):491-8. PubMed ID: 14614913
[TBL] [Abstract][Full Text] [Related]
11. Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway.
Andreou AP; Goadsby PJ
Cephalalgia; 2011 Oct; 31(13):1343-58. PubMed ID: 21893557
[TBL] [Abstract][Full Text] [Related]
12. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
Classey JD; Bartsch T; Goadsby PJ
Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of action of the 5-HT1B/1D receptor agonists.
Tepper SJ; Rapoport AM; Sheftell FD
Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
[TBL] [Abstract][Full Text] [Related]
14. Preclinical neuropharmacology of naratriptan.
Lambert GA
CNS Drug Rev; 2005; 11(3):289-316. PubMed ID: 16389295
[TBL] [Abstract][Full Text] [Related]
15. Blockade of 5-HT3 receptors with granisetron does not affect trigeminothalamic nociceptive transmission in rats: Implication for migraine.
Sokolov AY; Sivachenko IB; Panteleev SS; Lyubashina OA
Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):34-41. PubMed ID: 28853174
[TBL] [Abstract][Full Text] [Related]
16. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288.
Knight YE; Edvinsson L; Goadsby PJ
Neuropeptides; 1999 Feb; 33(1):41-6. PubMed ID: 10657470
[TBL] [Abstract][Full Text] [Related]
17. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: a Fos protein study.
Park J; Moon H; Akerman S; Holland PR; Lasalandra MP; Andreou AP; Ferrari MD; van den Maagdenberg AM; Goadsby PJ
Neurobiol Dis; 2014 Apr; 64():1-7. PubMed ID: 24355314
[TBL] [Abstract][Full Text] [Related]
18. The antimigraine 5-HT 1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain.
Kayser V; Aubel B; Hamon M; Bourgoin S
Br J Pharmacol; 2002 Dec; 137(8):1287-97. PubMed ID: 12466238
[TBL] [Abstract][Full Text] [Related]
19. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine?
Goadsby PJ; Hoskin KL
Ann Neurol; 1998 Jun; 43(6):711-8. PubMed ID: 9629840
[TBL] [Abstract][Full Text] [Related]
20. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
